Significance of Lncrna MIR31HG in Predicting the Prognosis for Chinese Patients with Cancer: A Meta-Analysis

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Fan YH , FangH, JiCX, XieH, XiaoB, ZhuXG. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: a meta-analysis. Clin. Chim. Acta466, 120–126 (2017).
   PubMed Web of Science ®Google Scholar
• Jiang MC , NiJJ, CuiWY, WangBY, ZhuoW. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am. J. Cancer Res.9(7), 1354–1366 (2019).
   PubMed Web of Science ®Google Scholar
• Zheng Y , GaoY, LiXet al. Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-beta A. Onco. Targets Ther.11, 4965–4977 (2018).
   PubMed Web of Science ®Google Scholar
• Hua JT , AhmedM, GuoHet al. Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19. Cell174(3), 564e518–575e518 (2018).
   Web of Science ®Google Scholar
• Sun L , WangL, ChenTet al. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. J. Cell. Mol. Med. doi:10.1111/jcmm.14705 (2019) ( Epub ahead of print).
   Google Scholar
• Xu Y , LiY, JinJet al. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol. Cancer18(1), 141 (2019).
   PubMed Web of Science ®Google Scholar
• Fan Y , YanT, ChaiY, JiangY, ZhuX. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer. Clin. Chim. Acta482, 224–230 (2018).
   PubMed Web of Science ®Google Scholar
• Yousefi H , MaheronnaghshM, MolaeiFet al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene doi:10.1038/s41388-019-1040-y (2019) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Fan Y , HeY, ZhouX, LiuY, WangF. Meta-analysis of the prognostic value of lncRNA DANCR for cancer patients in China. Cancer Manag. Res.11, 2027–2037 (2019).
   PubMedGoogle Scholar
• Cai P , LiH, HuoWet al. Aberrant expression of LncRNA-MIR31HG regulates cell migration and proliferation by affecting miR-31 and miR-31* in Hirschsprung's disease. J. Cell. Biochem.119(10), 8195–8203 (2018).
   PubMed Web of Science ®Google Scholar
• Gao J , ChenF, HuaMet al. Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes. Biol. Res.51(1), 30 (2018).
   PubMedGoogle Scholar
• Montes M , NielsenMM, MaglieriGet al. The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence. Nat. Commun.6, 6967 (2015).
   PubMed Web of Science ®Google Scholar
• Altman DG , McshaneLM, SauerbreiW, TaubeSE. REporting recommendations for tumor MARKer prognostic studies (REMARK): explanation and elaboration. PLoS Med.9(5), e1001216 (2012).
   PubMed Web of Science ®Google Scholar
• Harris AL . REporting recommendations for tumour MARKer prognostic studies (REMARK). Br. J. Cancer93(4), 385–386 (2005).
   PubMedGoogle Scholar
• Fan YH , JiCX, XuB, FanHY, ChengZJ, ZhuXG. Long noncoding RNA activated by TGF-beta in human cancers: a meta-analysis. Clin. Chim. Acta468, 10–16 (2017).
   PubMed Web of Science ®Google Scholar
• Mei H , LiuY, ZhouQ, HuK, LiuY. Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis. Biomark. Med.13(1), 45–54 (2019).
   PubMed Web of Science ®Google Scholar
• Chen J , ZhuJ. Elevated expression levels of long non-coding RNA, Loc554202, are predictive of poor prognosis in cervical cancer. Tohoku J. Exp. Med.243(3), 165–172 (2017).
   PubMed Web of Science ®Google Scholar
• Ding J , LuB, WangJet al. Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades. J. Exp. Clin. Cancer Res.34, 100 (2015).
   PubMed Web of Science ®Google Scholar
• He A , ChenZ, MeiH, LiuY. Decreased expression of LncRNA MIR31HG in human bladder cancer. Cancer Biomark.17(2), 231–236 (2016).
   PubMed Web of Science ®Google Scholar
• Li Y , XinS, WuHet al. High expression of microRNA31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin. Oncol. Rep.40(3), 1706–1724 (2018).
   PubMed Web of Science ®Google Scholar
• Nie FQ , MaS, XieM, LiuYW, DeW, LiuXH. Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer. Tumour Biol.37(6), 7693–7701 (2016).
   PubMedGoogle Scholar
• Qin J , NingH, ZhouY, HuY, YangL, HuangR. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma. Biomed. Pharmacother.99, 363–368 (2018).
   PubMed Web of Science ®Google Scholar
• Ren ZP , ChuXY, XueZQet al. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma. Eur. Rev. Med. Pharmacol. Sci.21(17), 3866–3870 (2017).
   PubMed Web of Science ®Google Scholar
• Shih JW , ChiangWF, WuATHet al. Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1alpha co-activator driving oral cancer progression. Nat. Commun.8, 15874 (2017).
   PubMed Web of Science ®Google Scholar
• Wang R , MaZ, FengLet al. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression. Mol. Cancer17(1), 162 (2018).
   PubMed Web of Science ®Google Scholar
• Yan S , TangZ, ChenKet al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J. Exp. Clin. Cancer Res.37(1), 214 (2018).
   PubMedGoogle Scholar
• Yang L , WeiH, XiaoHJ. Long non-coding RNA Loc554202 expression as a prognostic factor in patients with colorectal cancer. Eur. Rev. Med. Pharmacol. Sci.20(20), 4243–4247 (2016).
   PubMed Web of Science ®Google Scholar
• Suhail Y , CainMP, VanajaKet al. Systems biology of cancer metastasis. Cell Syst.9(2), 109–127 (2019).
   PubMed Web of Science ®Google Scholar
• Chang LC , FanCW, TsengWKet al. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer. Biomark. Med.11(12), 1103–1111 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou X , FanYH, WangY, WangF, LiuY. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis. Medicine (Baltimore)98(17), e15251 (2019).
   PubMed Web of Science ®Google Scholar
• Qi P , DuX. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol.26(2), 155–165 (2013).
   PubMed Web of Science ®Google Scholar
• Sun Y , JiaX, WangM, DengY. Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma. Cancer Manag. Res.11, 8055–8064 (2019).
   PubMed Web of Science ®Google Scholar
• Zheng S , ZhangX, WangX, LiJ. MIR31HG promotes cell proliferation and invasion by activating the Wnt/beta-catenin signaling pathway in non-small cell lung cancer. Oncol. Lett.17(1), 221–229 (2019).
   PubMed Web of Science ®Google Scholar
• Dandan W , JianliangC, HaiyanH, HangM, XuedongL. Long noncoding RNA MIR31HG is activated by SP1 and promotes cell migration and invasion by sponging miR-214 in NSCLC. Gene692, 223–230 (2019).
   PubMed Web of Science ®Google Scholar
• Eide PW , EilertsenIA, SveenA, LotheRA. Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties. Int. J. Cancer144(11), 2843–2853 (2019).
   PubMed Web of Science ®Google Scholar